Physician profile
Michael Pasquale
NPI 1013157791
$2,983.93
in general payments reported to CMS, 2019-2025
10 companies · $673 in 2025
The $673 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $947 · 2023: $84.54 · 2024: $1,128 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,485.70 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $684.97 | 2023-2025 | Navitor, Mitraclip |
| Boston Scientific Corporation | $317.13 | 2024 | Watchman Flx |
| Edwards Lifesciences Corporation | $136.09 | 2022-2025 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $133.44 | 2021 | |
| Pfizer INC. | $97.77 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $48.16 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $37.74 | 2023-2024 | Gore Cardioform Septal Occluder |
| Atricure, INC. | $27.71 | 2025 | Atriclip Laa Exclusion System |
| E.R. Squibb & Sons, L.L.C. | $15.22 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pasquale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.